Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing, suitable for open surgery and minimally invasive surgical procedures (MIS)
Baxter International Inc. (BAX)
Last baxter international inc. earnings: 4/30 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
investor.baxter.com
Company Research
Source: PR Newswire
DEERFIELD, Ill., May 20, 2025 /PRNewswire/ -- "Hemopatch Sealing Hemostat represents a significant development from Baxter, and introducing the room-temperature variant highlights our ongoing dedication to innovation in Tissue Management," stated Steve Wallace, President of Advanced Surgery at Baxter.Building on a decade of market success, Baxter is excited to unveil Hemopatch Sealing Hemostat which now offers the convenience of room-temperature storage and an extended shelf life of 3 years.The performance of Hemopatch Sealing Hemostat involves the interaction of two components that can create rapid and lasting hemostasis by sealing off the bleeding surface. The white, tissue-facing side of Hemopatch Sealing Hemostat is covered with a thin layer of NHS-PEG. The NHS-PEG, when in contact with blood or other body fluids forms a hydrogel which enhances its adhering properties and seals the tissue surface. In contact with blood, collagen induces aggregation of platelets. Platelets deposit
Show less
Read more
Impact Snapshot
Event Time:
BAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAX alerts
High impacting Baxter International Inc. news events
Weekly update
A roundup of the hottest topics
BAX
News
- Baxter International Inc. (BAX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International and Molina Healthcare on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- Baxter International, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights – BAXGlobeNewswire
- BAX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAXGlobeNewswire
BAX
Earnings
- 10/30/25 - Beat
BAX
Sec Filings
- 12/22/25 - Form 8-K
- 12/16/25 - Form 4
- 12/10/25 - Form 3
- BAX's page on the SEC website